REINHARDT MAX 4
4 · Orthofix Medical Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Orthofix (OFIX) President Max Reinhardt Sells 2,133 Shares
What Happened Max Reinhardt, President, Global Spine at Orthofix Medical (OFIX), sold a total of 2,133 shares in two open-market/private transactions to satisfy tax-withholding on restricted stock units (sell-to-cover). On 2026-03-04 he sold 1,080 shares at a weighted average price of $12.92 for approximately $13,950; on 2026-03-05 he sold 1,053 shares at a weighted average price of $12.55 for approximately $13,216. Combined proceeds were about $27,166 (overall weighted avg ≈ $12.74/share).
Key Details
- Transaction dates: 2026-03-04 (1,080 shares @ weighted avg $12.92, price range $12.80–$13.03) and 2026-03-05 (1,053 shares @ weighted avg $12.55, price range $12.48–$12.72). (See footnotes F2, F4.)
- Reason: Sell-to-cover to satisfy tax withholding in connection with RSU settlement; sales were pre-authorized and made without the reporting person's discretion (footnote F1).
- Holdings after transaction: filing notes inclusion of 19,417 previously reported restricted stock units (footnote F3). The filing did not disclose a complete post-transaction beneficial ownership total in the materials provided here.
- Filing: Report filed on 2026-03-06 for transactions on 2026-03-04 and 2026-03-05; appears to be timely.
Context
- These sales were tax-withholding (sell-to-cover) related to RSU settlement, which is a routine administrative transaction (code S/F for sale/tax withholding) and not the same signal as an unsolicited open-market sale for liquidity or portfolio reasons.
- No options were exercised and no discretionary trading plan (e.g., 10b5-1) is indicated in the provided notes; the filing states the sale was mandated by the compensation committee’s pre-existing sell-to-cover requirement.
Insider Transaction Report
Form 4
REINHARDT MAX
President, Global Spine
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-04$12.92/sh−1,080$13,950→ 26,401 total - Sale
Common Stock
[F1][F4][F3]2026-03-05$12.55/sh−1,053$13,216→ 25,348 total
Footnotes (4)
- [F1]Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
- [F3]Includes 19,417 previously reported restricted stock units.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive.
Signature
/s/ J. Andres Cedron, Attorney-in-fact|2026-03-06